Description

Tirzepatide is a synthetic research peptide that acts as a
dual receptor agonist targeting the GLP-1 (glucagon-like peptide-1)
and GIP (glucose-dependent insulinotropic polypeptide) receptors.
In laboratory research, Tirzepatide is studied for its role in
regulating glucose metabolism, energy metabolism, and appetite in vitro. Tirzepatide is manufactured to high quality standards and tested using
high-performance liquid chromatography (HPLC) to ensure maximum purity and consistency.
It is ideal for biochemical and endocrinological research in a controlled laboratory environment.

Important specifications

Feature	Value / explanation
Name	Tirzepatide
Synonym	LY3298176
Form	Lyophilisate (dry powder)
Purity	≥ 99% (HPLC tested)
Storage conditions	Chilled, protected from light and moisture

Research relevance

Under investigation as a GLP-1/GIP dual agonist for insight into energy and glucose homeostasis.
Relevant peptide in studies of metabolic processes and receptor activity .
Important reference material in incretin-related research.

Additional information

Vial	2 MG (10 Vial), 5 MG (10 Vial), 10 MG (10 Vial), 15 MG (10 Vial), 20 MG (10 Vial), 30 MG (10 Vial), 40 MG (10 Vial), 50 MG (10 Vial), 60 MG (10 Vial), 100 MG (10 Vial)